The beta cells from T2DM subjects contain elevated levels of IL-1β, a potent pro-inflammatory cytokine, and reduced levels of IL-1 receptor antagonist (IL-1ra) [25]. This evidence concerns the gene IL1B and type 2 diabetes mellitus.